Standout Papers

Liraglutide and Renal Outcomes in Type 2 Diabetes 2017 2026 2020 2023 823
  1. Liraglutide and Renal Outcomes in Type 2 Diabetes (2017)
    Johannes F.E. Mann, David D. Ørsted et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 9 from Science/Nature 87 standout
Sub-graph 1 of 20

Citing Papers

Mapping the effectiveness and risks of GLP-1 receptor agonists
2025 Standout
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
3 intermediate papers

Works of David D. Ørsted being referenced

Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke
2018
Liraglutide and Renal Outcomes in Type 2 Diabetes
2017 Standout

Author Peers

Author Last Decade Papers Cites
David D. Ørsted 594 1092 243 430 32 2.3k
Thoralf Wendt 969 1403 259 241 33 4.7k
Man K. Chan 504 547 120 492 68 2.4k
Martin Andrassy 822 461 229 321 46 3.3k
Michael Morcos 482 517 150 117 40 2.5k
Ian C. Wilson 290 405 163 558 55 2.1k
Alessandro Blè 432 548 209 308 48 3.6k
Anastasios Kalofoutis 448 438 197 291 56 2.2k
Marie Pigeyre 600 907 91 937 81 3.4k
Heinrich E. Lob 520 602 215 277 25 3.2k
Paul D. Woolf 365 1471 277 449 85 3.7k

All Works

Loading papers...

Rankless by CCL
2026